On this page
Nutropin AQ
somatropin
351(a) Standalone BLA
Overview
Source: Purple BookProprietary name
Nutropin AQ
Proper name
somatropin
Licence type
351(a)
BLA number
020522
Applicant
Genentech, Inc.
Center
CDER
Presentations
6
First licensure
—
Presentations
Source: Purple Book| Strength | Dosage form | Route | Presentation | Status | Licensed |
|---|---|---|---|---|---|
| 10MG/2ML | Injection | Subcutaneous | Vial | Disc | December 29, 1995 |
| 10MG/2ML | Injection | Subcutaneous | Multi-Dose Cartridge | Disc | April 22, 2002 |
| 10MG/2ML | Injection | Subcutaneous | Autoinjector | Disc | January 3, 2008 |
| 20MG/2ML | Injection | Subcutaneous | Autoinjector | Disc | January 3, 2008 |
| 20MG/2ML | Injection | Subcutaneous | Multi-Dose Cartridge | Disc | January 3, 2008 |
| 5MG/2ML | Injection | Subcutaneous | Autoinjector | Disc | January 3, 2008 |
Sources for this page
| Purple Book | FDA | Licence type, presentations, reference product, exclusivity |